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298 Mechanical reperfusion: stenting and other additional procedures /  The culprit lesion in acute coronary syndromes
Outcomes from intracoronary aspiration 
thrombectomy for acute myocardial infarction
Tatsuaki Murakami, Sumio Mizuno, Kazuo Ohsato, Yoshtfumi Takahashi, 
Masateru Ohnaka. Fukui Cardiovascular Center, Fukui, Japan
We applied intracoronary aspiration thrombectomy (1CAT) to recanalization 
therapy for acute myocardial infarction (AMI), using Probing catheter™ to 
aspirate intracoronary occlusive tissues. To elucidate therapeutic values of 
(CAT and pathogenesis of acute myocardial infarction, we assigned ICAT or 
primary PTCAto patients with evolving AMI (TIMI 0),
Methods: We investigated primary clinicoangiographic outcomes and histopatho 
logic outcomes of aspirated thrombi (AT) in 45 patients treated by ICAT, and 
compared the outcomes with those from primary PTCA in 48 patients.
Results: 1: No significant complications (procedural sheath, emergent bypass 
graft surgery) occurred. 2: Recanalization (TIMI 3 or 2) was achieved in 27 
(60%) patients with ICAT alone and in 41 (91%) patients with ICAT alone or 
ICAT followed by PTCA. 3: Histology of AT was defined as, recent thrombi (R) 
in 23 (51%) cases, atheroma (A) in 6 (13%) cases, no thrombi (N) in 13 (29%) 
cases, and organized thrombi in 1 case. 4: In cases of (R) ICAT alone provided 
recanalization more frequently than jn those of (A) or In those of (N), (R, A, 
N,: 20/23 (87%), 3/6 (50%), 4/13 (31%), respectively, p < 0.001). 5: Baseline 
clinicoangiographic characteristics were well balanced in patients undergoing 
the two recanalization strategies. There was no significant difference in primary 
recanalization rate (ICAT alone or ICAT followed by PTCA vs primary PTCA; 
91% vs 92%) or incidence of complications (procedural death, 0% vs 2%; 
emergent bypass graft surgery, 0% vs 0%) between the two strategies. 6: 
Number of balloon catheter used were smaller in ICAT than those in PTCA 
(ICAT alone or ICAT followed by PTCA vs primary PTCA; 1.0 ±  0.1 vs 1.5 ±  
0.1, p < 0,001).
These results indicate that the development of AMI seems heterogeneous in 
each individual case, and ICAT complies strategic considerations for recanal­
ization therapies in some patients with AMI.
Antiplatelet therapy versus anticoagulatlon after 
coronary Palmaz-Schatz stent placement in acute 
myocardial infarction. A prospective randomized 
study within the ISAR trial
F.-J. Neumann, H. Schühlen, H. Walter, M. Hadamltzky, E. Zltzmann-Roth*
R, Blasini, G. Richardt, E. Alt, C. Schmitt, A. Schomig. 7. Med. Klinik, Klinikum 
rechts der Isar, Tech. Universität München, Germany
In the ISAR (Intracoronary Stenting and Antithrombotic Regimen) Trial, 517 
patients were randomized to either antiplatetet therapy or anticoagulatlon, 123 
were patients in acute myocardial infarction. The anticoagulation (AC) protocol 
consisted of aspirin (100 mg bid) + phenprocoumon + iv-heparin until the target- 
INR of 3.5 was reached. The antiplatelet (AP) protocol consisted of aspirin (100 
mg bid) + ticlopidine (250 mg bid). Phenprocoumon or ticlopidine were given 
for 4 weeks. There were no significant differences in clinical and angiographic 
baseline data between AC and AP. Within 30 days after the procedure, there 
were significantly fewer noncardiac events (noncardiac death, cerebrovascular 
accident, organ bleeding or groin complications requiring surgery or transfu­
sions, or impairing organ function) with AP (1.6% vs. 24.2.% with AC; relative 
risk (RR) 0.07; 95%>confldence interval (Cl) 0.00-0.42). The cardiac event 
rate (cardiac death, myocardial infarction, repeat PTCA, CABG) was lower with 
AP (1.6% vs. 9.7%; RR 0.17; Cl 0.00-1.34). No thrombotic stent occlusion 
occurred with AP, but in 9.7% with AC (p < 0.03).
In this high-risk group of patients with acute myocardial Infarction, antiplatelet 
therapy with aspirin + ticlopidine is associated with a lower rate of noncardiac 
as well as cardiac complications in comparison to anticoagulatlon with aspirin 
+ phenprocoumon + overlapping heparin.
THE CULPRIT LESION IN ACUTE CORONARY
SYNDROMES
1656 The use of cardiac catheterization and coronary 
angioplasty post myocardial infarction in Europe: 
observations from the GUSTO I trial
K.J. Beatt, F. van de Werf, M.L. Simoons, A. Vahanian, R. Califf, E. Topol for 
the GUSTO Investigators. Cardiac Department, Charing Cross Hospital, 
London, UK
The need for invasive investigation post myocardial infarction (Ml) has been 
the subject of considerable controversy in recent years. A strategy of "wait and 
see" has been broadly adopted by many units. To obtain a view of current 
practice in Europe the data from the GUSTO I trial was reviewed and the rate 
of coronary angiography and coronary angioplasty in the first thirty days were 
compared by country.
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The countries with a catheterisation rate below 20% showed a small non 
significance increase in overall mortality (8.3% v 7.2%) and a modest but highly 
significant increase in mortality between hospital discharge and 30 days (1.3% 
vO.2% p ■< 0,0001).
There are surprisingly large differences in the use of invasive investigation 
post Ml which have considerable financial implications. Perhaps most pertinent 
will be the long term follow-up as recent data has suggested that the true 
magnitude of benefit of revascularisation after Ml may not become evident until 
2-3 years. This data will be presented.
Complex lesion morphology after successful 
thrombolysis is not associated with an adverse early 
and long-term outcome
G. Veen, C.C. de Cock, F.W.A. Verheugt. Department of Cardiology, Free 
University Hospital, Amsterdam; St. Radboud Hospital, Nijmegen, The 
Netherlands
tn the APRlCOT-study we performed coronary angiography within 48 hours 
(mean 23 h) after successful thrombolysis for acute myocardial infarction (AMI) 
in 284 patients (pts). Culprit lesion morphology was scored as complex or 
smooth. Follow-up was done up to three years after the AMI.
At baseline 161 pts had a smooth and 123 a complex lesion. There were 
no differences between age, male/female ratio and quantitative angiographic 
parameters. Complex lesions were more present in the right coronary artery 
(55% vs 33%; p < 0.005), with a higher incidence of multivessel disease (50% 
vs 37%; p < 0.05). Reocclusion rate of complex lesions was lower at three 
months (second angiogram in 248 pts.): 23% vs 34% (p < 0.05).
The figure shows the 3-years follow-up for the combined endpoint of death 
and recurrent Mi. It shows, that pts. with complex lesions have a slightly better 
early and long-term outcome (NS).
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Conclusion: Complex morphology of the infarct-related artery early after 
successful thrombolysis for AMI is not associated with an adverse prognosis. 
Possible factors are the lower reocclusion rates at 3 months and a higher 
incidence of right coronary involvement.
